Rosa I. Gallagher

1.8k citations

27 papers · 808 indexed · h-index 15

Molecular Biology
Oncology top 10%
Cancer Research top 10%
Radiology, Nuclear Medicine and Imaging top 10%
Genetics top 10%

Co-authors: Julia Wulfkuhle Virginia Espina Emanuel F. Petricoin Lance A. Liotta H. Kim Lyerly Xiaoyi Yang Sumin Zhao Lei-Hua Liu
Topics: HER2/EGFR in Cancer Research (8 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Advanced Biosensing Techniques and Applications (4 papers)
Cited by: Genetics Oncology Cancer Research
Journals: Journal of Clinical Oncology PLoS ONE Cancer Research
Partner nations: United States China Austria

In The Last Decade

Rosa I. Gallagher

25 papers receiving 798 citations

Peers

Countries citing papers authored by Rosa I. Gallagher

Since Specialization

Citations

This map shows the geographic impact of Rosa I. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa I. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa I. Gallagher more than expected).

Fields of papers citing papers by Rosa I. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa I. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa I. Gallagher. The network helps show where Rosa I. Gallagher may publish in the future.

Co-authorship network of co-authors of Rosa I. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa I. Gallagher. A scholar is included among the top collaborators of Rosa I. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa I. Gallagher. Rosa I. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer 2025 ·Clinical Cancer Research ·Emanuel F. Petricoin,Denise M. Wolf,Christina Yau,Julia Wulfkuhle,Laura van ‘t Veer,Rosa I. Gallagher,Laura J. Esserman,Gillian L. Hirst,Lamorna Brown Swigart,Douglas Yee	0
2	Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance 2023 ·Cancer Biology & Therapy ·David J. Zahavi,Rossin Erbe,Yongwei Zhang,Theresa Guo,Zoe X. Malchiodi,(unknown),(unknown),Rosa I. Gallagher,Julia Wulfkuhle,Emanuel F. Petricoin,Sandra A. Jablonski,Elana J. Fertig,Louis M. Weiner	1
3	Synthesis of 2-oxoquinoline derivatives as dual pim and mTORC protein kinase inhibitors 2022 ·Medicinal Chemistry Research ·(unknown),Kōichi Okumura,(unknown),Rosa I. Gallagher,Julia Wulfkuhle,Emanuel F. Petricoin,Sathish K.R. Padi,(unknown),Zhiyong He,Wei Wang,Andrew S. Kraft	1
4	Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer 2021 ·Clinical Cancer Research ·Paula I. González-Ericsson,(unknown),Rosa I. Gallagher,Xiaopeng Sun,Margaret L. Axelrod,Quanhu Sheng,Na Luo,Henry Gómez,Violeta Sánchez,Melinda E. Sanders,Lajos Pusztai,Emanuel Petricoin,Kim Blenman,Justin M. Balko,(unknown)	54
5	Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer 2021 ·Clinical Cancer Research ·Zhen Shi,Julia Wulfkuhle,Małgorzata Nowicka,Rosa I. Gallagher,Cristina Saura,Paolo Nucíforo,Isabel Calvo,Jay Andersen,José Luís Passos‐Coelho,Miguel Gil‐Gil,Begoña Bermejo,(unknown),Eva Ciruelos,Patricia Villagrasa,Matthew Wongchenko,Emanuel F. Petricoin,Mafalda Oliveira,Steven J. Isakoff	31
6	Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial 2020 ·npj Breast Cancer ·Denise M. Wolf,Christina Yau,Julia Wulfkuhle,Lamorna Brown Swigart,Rosa I. Gallagher,Mark Jesus M. Magbanua,(unknown),Gillian L. Hirst,(unknown),Smita Asare,Debu Tripathy,Don Berry,Laura J. Esserman,A. Jo Chien,Emanuel F. Petricoin,Laura van ‘t Veer	25
7	Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma 2018 ·Clinical Cancer Research ·Nichola Cruickshanks,Ying Zhang,(unknown),Myron Gibert,Fang Yuan,(unknown),Cassandra Grello,(unknown),Collin Dube,Fadila Guessous,Baomin Wang,Ciana Deveau,Karim Saoud,Rosa I. Gallagher,Julia Wulfkuhle,David Schiff,See Phan,Emanuel F. Petricoin,Roger Abounader	35
8	Phosphorylation of AKT kinase substrates to predict response to the AKT inhibitor MK2206 in the I-SPY 2 trial in both HER2- and HER2+ patients. 2018 ·Journal of Clinical Oncology ·Julia Wulfkuhle,Denise M. Wolf,Christina Yau,Rosa I. Gallagher,Lamorna Brown Swigart,Gillian L. Hirst,Laura J. Esserman,Donald A. Berry,Laura van ‘t Veer,Emanuel F. Petricoin,(unknown)	1
9	Targetable T-type Calcium Channels Drive Glioblastoma 2017 ·Cancer Research ·Ying Zhang,Nichola Cruickshanks,Fang Yuan,Baomin Wang,(unknown),Julia Wulfkuhle,Rosa I. Gallagher,Alexander F. Koeppel,(unknown),(unknown),Jeongwu Lee,Eli E. Bar,David Schiff,Stephen Turner,Emanuel F. Petricoin,Lloyd S. Gray,Roger Abounader	81
10	Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL 2017 ·Blood Advances ·Kallesh D. Jayappa,Craig A. Portell,Vicki L. Gordon,Brian J. Capaldo,Stefan Bekiranov,Mark J. Axelrod,(unknown),Julia Wulfkuhle,Rosa I. Gallagher,Emanuel F. Petricoin,Timothy P. Bender,Michael E. Williams,Michael J. Weber	81
11	Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer 2017 ·Molecular Cancer Therapeutics ·Melita A. Gordon,Nicholas C. D’Amato,Haihua Gu,Beatrice Babbs,Julia Wulfkuhle,Emanuel F. Petricoin,Rosa I. Gallagher,Ting Dong,Kathleen C. Torkko,Bolin Liu,Anthony Elias,Jennifer K. Richer	41
12	Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells 2017 ·Oncotarget ·(unknown),Aisha Naeem,Erika Parasido,(unknown),(unknown),Deborah L. Berry,(unknown),Richard J. Lee,Adam S. Feldman,Chukwuemeka Ihemelandu,Maria Laura Avantaggiati,Deepak Kumar,Stephen W. Byers,Rosa I. Gallagher,Julia Wulfkuhle,Emanuel F. Petricoin,Olga Rodriguez,Chris Albanese	16
13	Protein activation mapping and exploratory predictive markers for pCR in triple-negative breast cancer patients treated with neratinib in the I-SPY 2 TRIAL. 2015 ·Journal of Clinical Oncology ·Julia Wulfkuhle,Christina Yau,Denise M. Wolf,Rosa I. Gallagher,Jianghong Deng,Lamorna Brown Swigart,Gillian L. Hirst,Minetta C. Liu,John W. Park,Laura J. Esserman,Donald A. Berry,Laura van’t Veer,Emanuel F. Petricoin,(unknown)	2
14	A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer 2014 ·Breast Cancer Research and Treatment ·Gayle Jameson,Emanuel F. Petricoin,Jasgit C. Sachdev,Lance A. Liotta,David Loesch,Stephen P. Anthony,Manpreet Chadha,Julia Wulfkuhle,Rosa I. Gallagher,(unknown),Mariaelena Pierobon,(unknown),(unknown),(unknown),(unknown),Daniel D. Von Hoff,Nicholas J. Robert	57
15	Reverse Phase Protein Arrays: Mapping the Path Towards Personalized Medicine 2014 ·Molecular Diagnosis & Therapy ·Rosa I. Gallagher,Virginia Espina	32
16	An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models 2013 ·Breast Cancer Research ·Wenle Xia,(unknown),Sumin Zhao,Lei-Hua Liu,Takuya Osada,Qing Cheng,Julia Wulfkuhle,William R. Gwin,Xiaoyi Yang,Rosa I. Gallagher,Sarah Bacus,H. Kim Lyerly,Neil L. Spector	113
17	Reverse Phase Protein Microarrays: Fluorometric and Colorimetric Detection 2011 ·Methods in molecular biology ·Rosa I. Gallagher,Alessandra Silvestri,Emanuel F. Petricoin,Lance A. Liotta,Virginia Espina	13
18	Laser Capture Microdissection: ArcturusXT Infrared Capture and UV Cutting Methods 2011 ·Methods in molecular biology ·Rosa I. Gallagher,(unknown),Lance A. Liotta,Virginia Espina	24
19	Correlation of molecular effects and pathologic complete response to preoperative lapatinib and trastuzumab, separately and combined prior to neoadjuvant breast cancer chemotherapy. 2011 ·Journal of Clinical Oncology ·(unknown),Yasir M. Nagarwala,Virginia Espina,L. A. Liotta,Michael Danso,Rosa I. Gallagher,Kristi McIntyre,(unknown),(unknown),Allison Florance,T Anderson,Joyce O’Shaughnessy	37
20	Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival 2010 ·PLoS ONE ·Virginia Espina,Brian D. Mariani,Rosa I. Gallagher,Khoa D. Tran,(unknown),(unknown),(unknown),Claudius Mueller,Luana Adamo,Jianghong Deng,Emanuel F. Petricoin,Lucio Pastore,Syed M. A. Zaman,Geetha Menezes,(unknown),(unknown),Kirsten H. Edmiston,Lance A. Liotta	111

About Rosa I. Gallagher

Rosa I. Gallagher is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 808 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Biosensing Techniques and Applications (4 papers). The work is most often cited by research in Genetics (140 citations), Oncology (345 citations) and Cancer Research (184 citations). Rosa I. Gallagher has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Julia Wulfkuhle, Virginia Espina, Emanuel F. Petricoin, Lance A. Liotta, Emanuel F. Petricoin, H. Kim Lyerly, Xiaoyi Yang, Sumin Zhao, Lei-Hua Liu and Sarah Bacus. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact